Australia TGA ARTG record

Lubricant, eye

Australia TGA ARTG Registered Device · AFT Pharmaceuticals Pty Ltd · Novaliq GmbH · Class IIa · Started October 03, 2017

Good Name: AFT Pharmaceuticals Pty Ltd - Lubricant, eye

Device classification

Risk Class: Class IIa
Product Type: Single Device Product
ARTG Category: General

Registration information

Start Date: October 03, 2017
Effective Date: October 03, 2017

Sponsor

Name: AFT Pharmaceuticals Pty Ltd

Manufacturer

Name: Novaliq GmbH
Country: Germany
Address: Im Neuenheimer Feld 515, Heidelberg, 69120

Intended purpose

Perfluorohexyloctane ophthalmic solution eye drops are used for lubricating the eye surface and stabilising the tear film to alleviate symptoms associated with dry eye.

About this record

Access comprehensive regulatory information for Lubricant, eye in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class IIa is sponsored by AFT Pharmaceuticals Pty Ltd, manufactured by Novaliq GmbH in Germany. The device registration started on October 03, 2017.

This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.